06Jan/14

NICE issues Final Appraisal Determination for PIXUVRI (pixantrone) drug – News-Medical.net

NICE issues Final Appraisal Determination for PIXUVRI (pixantrone) drug
News-Medical.net
showing PIXUVRI’s cost effectiveness and recommended the treatment as an option for certain people with histologically confirmed aggressive B-cell NHL who have previously received rituximab and are receiving PIXUVRI as a third- or fourth-line
PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from Sacramento Bee

all 5 news articles »